Patents Assigned to onCour Pharma, Inc.
  • NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF CYTOKINE STORM SYNDROME (CSS) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
    Publication number: 20230190895
    Abstract: Provided herein are compositions that comprise negatively charged particles and methods of making and using the same. Also provided are methods of reducing or treating Cytokine Storm Syndrome (CSS) or Acute Rcspiratoiy Distress Syndrome (ARDS).
    Type: Application
    Filed: April 29, 2021
    Publication date: June 22, 2023
    Applicant: onCOUR Pharma, Inc.
    Inventors: John PUISIS, Jim HERRMANN
  • Immune-modifying nanoparticles for the treatment of inflammatory diseases
    Patent number: 11045492
    Abstract: The current invention involves the administration of negatively charged particles, such as polystyrene, PLGA, or diamond particles, to subjects to ameliorate inflammatory immune responses. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same negatively charged particles.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: June 29, 2021
    Assignee: onCour Pharma, Inc.
    Inventor: John Puisis
  • Modified immune-modulating particles
    Patent number: 11020424
    Abstract: The presently claimed invention relates to methods of reducing the duration or severity of an inflammatory immune response. In embodiments, the method comprises administering poly (lactic acid) (PLA) particles, poly (glycolic acid) (PGA) particles, poly (lactic-co-glycolic acid) (PLGA) particles, or combinations thereof; wherein said particles are modified to contain one or more carboxyl groups on the particle's surface. In embodiments, the particles do not comprise therapeutically active ingredients.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: June 1, 2021
    Assignee: onCour Pharma, Inc.
    Inventors: Daniel R. Getts, Rachael Terry, Nicholas King